VA
KROS icon

VR Adviser’s Keros Therapeutics KROS Stock Holding History

VR Adviser’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-272,306
Closed -$11.6M – 30
2021
Q2 		$11.6M Sell
272,306
-100,000
-27% -$5.42M 1.4% 22
2021
Q1 		$22.9M Sell
372,306
-300,000
-45% -$19M 2.49% 15
2020
Q4 		$47.4M Hold
672,306
– – 6.97% 7
2020
Q3 		$25.9M Hold
672,306
– – 5.07% 6
2020
Q2 		$25.2M Buy
+672,306
New +$20.7M 6.04% 6

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return